Descriptive Epidemiology of Hospitalization of Patients with a Rare Tumor in an Italian Region
暂无分享,去创建一个
[1] F. Petrelli,et al. Efficacy of Immune Checkpoint Inhibitors in Rare Tumours: A Systematic Review , 2021, Frontiers in Immunology.
[2] J. Wisnivesky,et al. Effect of treatment center volume on outcomes in gastroenteropancreatic neuroendocrine tumor patients , 2018, BMC Cancer.
[3] P. Casali,et al. Rationale of the rare cancer list: a consensus paper from the Joint Action on Rare Cancers (JARC) of the European Union (EU) , 2020, ESMO Open.
[4] G. Tagliabue,et al. Epidemiology and biological characteristics of male breast cancer in Italy , 2020, Breast Cancer.
[5] G. Gatta,et al. Where Are Adolescents with Soft Tissue Sarcomas Treated? An Italian Nationwide Study on Referrals Based on Hospital Discharge Records. , 2020, Journal of adolescent and young adult oncology.
[6] D. Taruscio,et al. A National Hospital‐Based Study of Hospitalized Patients With Primary Biliary Cholangitis , 2019, Hepatology communications.
[7] D. Serraino,et al. Sensitivity and specificity of breast cancer ICD-9-CM codes in three Italian administrative healthcare databases: a diagnostic accuracy study , 2018, BMJ Open.
[8] D. Serraino,et al. Accuracy of colorectal cancer ICD-9-CM codes in Italian administrative healthcare databases: a cross-sectional diagnostic study , 2018, BMJ Open.
[9] D. Serraino,et al. Validating malignant melanoma ICD-9-CM codes in Umbria, ASL Napoli 3 Sud and Friuli Venezia Giulia administrative healthcare databases: a diagnostic accuracy study , 2018, BMJ Open.
[10] Jesse S Boehm,et al. Emerging Opportunities for Target Discovery in Rare Cancers. , 2017, Cell chemical biology.
[11] Eva Ardanaz,et al. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study. , 2017, The Lancet. Oncology.
[12] R. K. Pillai,et al. Rare cancers: Challenges & issues , 2017, The Indian journal of medical research.
[13] John P. A. Ioannidis,et al. What does research reproducibility mean? , 2016, Science Translational Medicine.
[14] G. Gatta,et al. Italian cancer figures--Report 2015: The burden of rare cancers in Italy. , 2016, Epidemiologia e prevenzione.
[15] G. Gatta,et al. Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project. , 2013, Cancer epidemiology.
[16] T. Trimble,et al. International rare cancers initiative. , 2013, The Lancet. Oncology.
[17] Martijn J Schuemie,et al. Chronic disease prevalence from Italian administrative databases in the VALORE project: a validation through comparison of population estimates with general practice databases and national survey , 2013, BMC Public Health.
[18] G. Eslick. What is a Rare Cancer? , 2012, Hematology/oncology clinics of North America.
[19] A. Giordano,et al. The burden of breast cancer in Italy: mastectomies and quadrantectomies performed between 2001 and 2008 based on nationwide hospital discharge records , 2012, Journal of experimental & clinical cancer research : CR.
[20] G. Gatta,et al. The Burden of Rare Cancers in Italy: The Surveillance of Rare Cancers in Italy (RITA) Project , 2012 .
[21] G. Gatta,et al. The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project. , 2012, Tumori.
[22] G. Gatta,et al. Rare cancers are not so rare: the rare cancer burden in Europe. , 2011, European journal of cancer.
[23] H. Howe,et al. The Occurrence of Rare Cancers in U.S. Adults, 1995–2004 , 2010, Public health reports.
[24] Gemma Gatta,et al. The burden of rare cancers in Europe. , 2010, Advances in experimental medicine and biology.
[25] E. Faerstein,et al. A DICTIONARY OF EPIDEMIOLOGY , 2016 .
[26] J. Hilbe. Negative Binomial Regression: Preface , 2007 .
[27] E. Steliarova-Foucher,et al. Cancer in children and adolescents in Europe: developments over 20 years and future challenges. , 2006, European journal of cancer.
[28] K. Dear,et al. Strategy for randomised clinical trials in rare cancers , 2003, BMJ : British Medical Journal.
[29] Very rare cancers--a problem neglected. , 2001, The Lancet. Oncology.